Free Trial

Alphatec (ATEC) Competitors

Alphatec logo
$13.84 -0.18 (-1.25%)
As of 12:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ATEC vs. GMED, MASI, TFX, ITGR, ATRC, IART, OFIX, ANGO, SRDX, and ARAY

Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), and Accuray (ARAY). These companies are all part of the "health care equipment" industry.

Alphatec vs. Its Competitors

Globus Medical (NYSE:GMED) and Alphatec (NASDAQ:ATEC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Globus Medical has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

In the previous week, Globus Medical had 2 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for Globus Medical and 5 mentions for Alphatec. Globus Medical's average media sentiment score of 0.83 beat Alphatec's score of 0.68 indicating that Globus Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Globus Medical
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Alphatec
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 18.5% of Globus Medical shares are held by insiders. Comparatively, 20.9% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Globus Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Globus Medical$2.52B3.20$102.98M$2.6022.99
Alphatec$682.24M3.00-$162.12M-$1.13-12.25

Globus Medical has a net margin of 13.58% compared to Alphatec's net margin of -24.33%. Globus Medical's return on equity of 10.65% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Globus Medical13.58% 10.65% 8.86%
Alphatec -24.33%N/A -21.44%

Globus Medical presently has a consensus price target of $87.64, suggesting a potential upside of 46.60%. Alphatec has a consensus price target of $18.50, suggesting a potential upside of 33.62%. Given Globus Medical's higher possible upside, research analysts clearly believe Globus Medical is more favorable than Alphatec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globus Medical
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.57
Alphatec
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

Globus Medical beats Alphatec on 14 of the 16 factors compared between the two stocks.

Get Alphatec News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEC vs. The Competition

MetricAlphatecMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.05B$6.94B$9.08B$10.59B
Dividend YieldN/A1.16%5.69%4.71%
P/E Ratio-12.2627.6186.0127.55
Price / Sales3.00195.34539.22204.66
Price / CashN/A21.7337.9261.55
Price / Book-138.455.4212.946.77
Net Income-$162.12M$178.04M$3.30B$275.88M
7 Day Performance0.62%4.96%4.86%2.79%
1 Month Performance-12.37%12.97%10.02%9.25%
1 Year Performance160.73%34.11%84.11%35.91%

Alphatec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEC
Alphatec
4.2435 of 5 stars
$13.85
-1.2%
$18.50
+33.6%
+160.6%$2.05B$682.24M-12.26700
GMED
Globus Medical
4.9148 of 5 stars
$60.20
-0.5%
$87.64
+45.6%
-13.7%$8.17B$2.52B23.155,300Analyst Forecast
MASI
Masimo
4.3454 of 5 stars
$148.13
+0.6%
$194.60
+31.4%
+9.8%$8.00B$2.09B-17.395,600Analyst Downgrade
TFX
Teleflex
4.6242 of 5 stars
$127.66
-2.5%
$141.57
+10.9%
-45.3%$5.78B$3.05B30.0414,100Analyst Forecast
ITGR
Integer
3.9618 of 5 stars
$105.33
+0.3%
$139.57
+32.5%
-18.5%$3.68B$1.72B46.4011,000Positive News
Analyst Forecast
ATRC
AtriCure
2.9293 of 5 stars
$34.73
-0.2%
$50.89
+46.5%
+28.4%$1.73B$465.31M-45.101,300Analyst Forecast
IART
Integra LifeSciences
3.6293 of 5 stars
$14.50
-2.0%
$18.43
+27.1%
-15.3%$1.15B$1.61B-2.224,396News Coverage
Analyst Forecast
OFIX
Orthofix Medical
3.0399 of 5 stars
$14.17
-3.0%
$21.75
+53.5%
-4.8%$577.01M$799.49M-4.471,616Analyst Forecast
ANGO
AngioDynamics
4.0471 of 5 stars
$11.26
-3.3%
$19.33
+71.7%
+89.1%$479.57M$292.50M-14.44760Earnings Report
Analyst Forecast
Analyst Revision
SRDX
Surmodics
4.5273 of 5 stars
$28.70
-1.4%
$43.00
+49.8%
-24.8%$416.35M$126.08M-23.33450News Coverage
Positive News
Analyst Forecast
ARAY
Accuray
4.4481 of 5 stars
$1.71
+1.2%
$5.00
+192.4%
-8.7%$190.50M$458.51M-85.501,040News Coverage
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:ATEC) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners